Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the...
Cytosurge elects veteran biotech executive, investor, and company builder Luba Greenwood, J.D., to its Board of Directors
GlobeNewswire, Inc.
Luba Greenwood joins Cytosurge’s Board of Directors to support the company’s next phase of commercial growth and scientific progress as Cytosurge builds the causal data foundation for AI-driven drug discovery.
CryptoMondays Europe Announces “Bitcoin Unfiltered” Fireside Chat with Giacomo Zucco.
GlobeNewswire, Inc.
Zurich, Switzerland, July 20, 2026 (GLOBE NEWSWIRE) -- CryptoMondays Europe will host Bitcoin Unfiltered: A Fireside Chat with Giacomo Zucco on Monday, July 27, 2026, at 17:00 CEST. The live online session will feature Giacomo Zucco, one of...
INNOCOS Returns to Zurich as Longevity Forces a Reckoning Across Beauty, Wellness and Consumer Brands
EIN Presswire
The flagship summit convenes leaders to address the questions the industry can no longer avoid: proof, trust, diagnostics & the rise of the clinic as a channel.
Fairclough Palmer AG Modernises Private Market Infrastructure with Swiss Stock Exchange Targeting Global Startups & SMEs
EIN Presswire
Fairclough Palmer AG introduces EquityLink, a modern digital asset exchange providing global startups and SMEs a public style marketplace to raise capital.
Neoantigen Therapies Market To Reach $2.83 Billion By 2030 Driven By Expanding Industry Demand
EIN Presswire
The Business Research Company's Neoantigen Therapies Market To Reach $2.83 Billion By 2030 Driven By Expanding Industry Demand LONDON, GREATER LONDON, UNITED KINGDOM, July 20, 2026 /EINPresswire.com/ -- "The field of neoantigen therapies is...
Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference
GlobeNewswire, Inc.
Developing bispecific Radio-DARPins to engage multiple tumor targets simultaneously, improving precision and therapeutic efficacy Presentation outlines Radio-DARPins’ ability to match target and disease biology for improved outcomes...
Recloser Market Registering a CAGR of 6.2% By Driving Types, Applications, Technology and Trends, Forecast 2035
EIN Presswire
Asia-Pacific leads the Recloser Market at 38% global share, anchored by massive state-funded grid builds in China and India.
TTM Technologies Arrives at the 2026 Farnborough International Airshow
GlobeNewswire, Inc.
SANTA ANA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of advanced electronics and interconnect solutions for aerospace, defense, and high-technology markets, today...
Precision Turned Product Manufacturing Market to Reach US$179.7 Billion by 2033, Says Persistence Market Research
EIN Presswire
Rising demand for precision components and increased adoption of CNC manufacturing technologies are driving market growth.
VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 13, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced a collaboration with Ardigen S.A., an AI-driven computational partner for modern R&D...
A Swiss Design Icon in a New Colour: MONDAINE Unveils the Limited Edition Transformative Teal Wall Clock
EIN Presswire
The iconic Official Swiss Railways Station Clock is reimagined in the Colour of the Year 2026, introducing a bold new expression of Swiss design.
Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1
GlobeNewswire, Inc.
Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in Stargardt disease type 1, having met the primary efficacy endpoint, reduction in lesion growth Presentation to include positive update on secondary endpoints, with...
Ovulation Testing Kits Market to Reach US$ 4.3 Bn by 2032 at 6.2% CAGR | Persistence Market Research
EIN Presswire
BRENFORD, LONDON, UNITED KINGDOM, July 13, 2026 /EINPresswire.com/ -- The global ovulation testing kits market is witnessing steady growth as consumers increasingly adopt home-based fertility monitoring solutions.
Seoul Pavilion Successfully Concludes at VivaTech 2026, Europe’s Largest Tech Stage
EIN Presswire
Substantial business matching outcomes lead to investment and collaboration with major European enterprises and local investors PARIS, FRANCE, July 13, 2026 /EINPresswire.com/ -- * “Seoul Night” was held successfully, attended by over 70 local...
Green Roof Market Expected to Reach US$ 10.8 Billion by 2033, According to Persistence Market Research
EIN Presswire
Growth is fueled by urbanization, climate regulations, and green building adoption.
SGS helps food businesses prepare for new EU Listeria requirements
EIN Presswire
Exploring practical steps food business operators can take to prepare for compliance BAAR, SWITZERLAND, July 20, 2026 /EINPresswire.com/ -- SGS, the world's leading testing, inspection and certification company, has announced the release of a...
High-throughput Screening (HTS) Market to Grow from USD 27.66 Billion in 2026 to USD 45.90 Billion by 2031, at a CAGR of 10.7% – MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, July 20, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global high-throughput screening (HTS) market will grow from USD 27.66 billion in 2026 to USD 45.90 billion by 2031, at a CAGR of 10.7% during the forecast period....
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
GlobeNewswire, Inc.
ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer.
No easy answers: European research consortia take on major challenges
GlobeNewswire, Inc.
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine new Challenge Programme grants from the Novo Nordisk Foundation will support ambitious research across fungal diseases, cardiometabolic disease, soil health and non-equilibrium biological...
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.